Women's health

Why pharma doesn't invest in birth control

There hasn't been much innovation in women's birth control since the pill came to market nearly 60 years ago — because drug companies don't stand to make much from it, Bloomberg reports.

Where it stands: Only 2% of drug companies' annual revenue from contraceptives goes back into research and development, according to the Gates Foundation.

Abortion law fallout: Where each state stands if Roe v. Wade is overturned

Data: State abortion policy from the Guttmacher Institute, state legislative makeup from NARAL. Map: Kerrie Vila/Axios